Abstract

Cardiac surgeons who concentrate on coronary revascularization realize that not every coronary artery is the same. We also know after each anastomosis, whether done on a beating heart or under cross-clamp, if the graft will be successful. For years, we would rely on symptom or event recurrence or repeat cardiac catheterization to determine graft patency. Recently, experience has grown with a variety of Doppler flow signals, the most commonly used being transit-time flow meters. Today, many of us view these flow probes as an adjuvant crutch to give us confirmation of anastomotic quality; yet, parenthetically, there is a paucity of data to demonstrate shortor long-term graft patency with good intra-operative flow assessments. The article by Nordgaard and colleagues [1] describing the value and variance of pulsatility index (PI) highlights another immediate limitation of the flow meter — that being interpreting patterns of values registered by the flow meters and conveying that to quality of the bypass graft. PI is one of the more-valued measurements, and is regarded as an indicator of flow resistance, or more appropriately, as a potential stricture at the anastomotic site. The PI should be 50% for all grafts and territories, and ideally >65%. If both the PI and DF% give correlative good measurements, then, the certainty of graft quality and distal coronary perfusion can be objectively assessed with greater comfort. In no instance has the author seen a PI > 7 with a normal DF%, and if DF < 25%, there is a problem with the graft or target. Although the author uses a flow meter on each coronary revascularization case, it adds value under circumstances that needs confirmation (immediately) of graft flow for a difficult anastomosis, or endarterectomy, and/or vein patch. Even though graft flows have had excellent intraoperative PI and DF% characteristics, the author could observe, years later, vein-graft closure; therefore, it is still unclear how transit-time flow meters help guide long term patency. Subanalysis of the randomized onversus off-pump coronary artery bypass surgery trial (ROOBY) may provide insight on graft patency based on intra-operative flow meter measurements and correlative 1-year angiographic analysis [2]. Clearly, other factors exist to determine graft patency, and risk-factor-modifying medication and dual antiplatelet therapy are important; yet, only time will tell whether intraoperative flow meters help guide long-term results.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.